100 related articles for article (PubMed ID: 19235924)
1. Pleiotropic function of ezrin in human metastatic melanomas.
Federici C; Brambilla D; Lozupone F; Matarrese P; de Milito A; Lugini L; Iessi E; Cecchetti S; Marino M; Perdicchio M; Logozzi M; Spada M; Malorni W; Fais S
Int J Cancer; 2009 Jun; 124(12):2804-12. PubMed ID: 19235924
[TBL] [Abstract][Full Text] [Related]
2. Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin.
Lugini L; Lozupone F; Matarrese P; Funaro C; Luciani F; Malorni W; Rivoltini L; Castelli C; Tinari A; Piris A; Parmiani G; Fais S
Lab Invest; 2003 Nov; 83(11):1555-67. PubMed ID: 14615410
[TBL] [Abstract][Full Text] [Related]
3. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
4. Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells.
Burg MA; Grako KA; Stallcup WB
J Cell Physiol; 1998 Nov; 177(2):299-312. PubMed ID: 9766527
[TBL] [Abstract][Full Text] [Related]
5. The Janus-faced role of ezrin in "linking" cells to either normal or metastatic phenotype.
Brambilla D; Fais S
Int J Cancer; 2009 Nov; 125(10):2239-45. PubMed ID: 19588507
[TBL] [Abstract][Full Text] [Related]
6. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
7. DCC regulates cell adhesion in human colon cancer derived HT-29 cells and associates with ezrin.
Martín M; Simon-Assmann P; Kedinger M; Martin M; Mangeat P; Real FX; Fabre M
Eur J Cell Biol; 2006 Aug; 85(8):769-83. PubMed ID: 16762451
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma.
Zhu L; Ito T; Nakahara T; Nagae K; Fuyuno Y; Nakao M; Akahoshi M; Nakagawa R; Tu Y; Uchi H; Furue M
J Dermatol; 2013 Dec; 40(12):973-9. PubMed ID: 24303922
[TBL] [Abstract][Full Text] [Related]
9. Fusion hybrids with macrophage and melanoma cells up-regulate N-acetylglucosaminyltransferase V, beta1-6 branching, and metastasis.
Chakraborty AK; Pawelek J; Ikeda Y; Miyoshi E; Kolesnikova N; Funasaka Y; Ichihashi M; Taniguchi N
Cell Growth Differ; 2001 Dec; 12(12):623-30. PubMed ID: 11751457
[TBL] [Abstract][Full Text] [Related]
10. Insights into a single rod-like helix in activated radixin required for membrane-cytoskeletal cross-linking.
Hoeflich KP; Tsukita S; Hicks L; Kay CM; Tsukita S; Ikura M
Biochemistry; 2003 Oct; 42(40):11634-41. PubMed ID: 14529273
[TBL] [Abstract][Full Text] [Related]
11. Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
Cruz-Munoz W; Man S; Xu P; Kerbel RS
Cancer Res; 2008 Jun; 68(12):4500-5. PubMed ID: 18559492
[TBL] [Abstract][Full Text] [Related]
12. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.
Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A
J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914
[TBL] [Abstract][Full Text] [Related]
13. Actin-binding protein, Espin: a novel metastatic regulator for melanoma.
Yanagishita T; Yajima I; Kumasaka M; Kawamoto Y; Tsuzuki T; Matsumoto Y; Watanabe D; Kato M
Mol Cancer Res; 2014 Mar; 12(3):440-6. PubMed ID: 24337068
[TBL] [Abstract][Full Text] [Related]
14. alphaV integrin promotes in vitro and in vivo survival of cells in metastatic melanoma.
Koistinen P; Ahonen M; Kähäri VM; Heino J
Int J Cancer; 2004 Oct; 112(1):61-70. PubMed ID: 15305376
[TBL] [Abstract][Full Text] [Related]
15. Ezrin in primary cutaneous melanoma.
Ilmonen S; Vaheri A; Asko-Seljavaara S; Carpen O
Mod Pathol; 2005 Apr; 18(4):503-10. PubMed ID: 15475929
[TBL] [Abstract][Full Text] [Related]
16. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells.
Elliott BE; Meens JA; SenGupta SK; Louvard D; Arpin M
Breast Cancer Res; 2005; 7(3):R365-73. PubMed ID: 15987432
[TBL] [Abstract][Full Text] [Related]
17. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
18. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
[TBL] [Abstract][Full Text] [Related]
19. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
[TBL] [Abstract][Full Text] [Related]
20. A novel PKC-regulated mechanism controls CD44 ezrin association and directional cell motility.
Legg JW; Lewis CA; Parsons M; Ng T; Isacke CM
Nat Cell Biol; 2002 Jun; 4(6):399-407. PubMed ID: 12032545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
